Literature DB >> 6196702

The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal.

M L Bernstein, J J Buchino.   

Abstract

The histologic similarities between the craniopharyngioma and the ameloblastoma are well recognized and supported by their common embryologic origin from oral ectoderm. Differences in these lesions include a greater tendency for craniopharyngiomas to be cystic and form ghost cells and calcifications. The keratinizing and calcifying odontogenic cyst (KCOC), a lesion that features proliferating ameloblastic epithelium, ghost keratin, calcification, and cyst formation, may more precisely mimic the craniopharyngioma. The histologic features of twenty-seven craniopharyngiomas were studied. Twenty cases resembled KCOC microscopically. Two examples duplicated the histologic features of infiltrative ameloblastoma, while five showed characteristics of both lesions. This study shows that the range of histologic features in craniopharyngioma includes and spans both odontogenic lesions but more often simulates KCOC. The results suggest that the KCOC and the ameloblastoma may be closely related developmentally.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196702     DOI: 10.1016/0030-4220(83)90098-1

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  10 in total

Review 1.  Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke's cleft cyst with corticotroph adenoma.

Authors:  N Karavitaki; B W Scheithauer; J Watt; O Ansorge; M Moschopoulos; A V Llaguno; J A H Wass
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 2.  Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview.

Authors:  Ruth Prieto; José M Pascual
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

3.  Cystic tumors of the pituitary infundibulum: seminal autopsy specimens (1899 to 1904) that allowed clinical-pathological craniopharyngioma characterization.

Authors:  José M Pascual; Ruth Prieto; Maria Rosdolsky; Sewan Strauss; Inés Castro-Dufourny; Verena Hofecker; Eduard Winter; Rodrigo Carrasco; Walter Ulrich
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

4.  Beta-catenin mutations are frequent in calcifying odontogenic cysts, but rare in ameloblastomas.

Authors:  Shigeki Sekine; Sunao Sato; Takashi Takata; Yasuo Fukuda; Takeshi Ishida; Mitsunobu Kishino; Tatsuhiro Shibata; Yae Kanai; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

5.  Ossified adamantinous type craniopharyngiomas. A series of 13 patients.

Authors:  S Palaoğlu; A Akbay; G Mocan; B Onol; O E Ozcan; T Ozgen; V Bertan
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

6.  Comparative immunohistochemical assessment of craniopharyngioma and related lesions.

Authors:  Brian H Le; Javad Towfighi; Silloo B Kapadia; M Beatriz S Lopes
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

7.  Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.

Authors:  Jacob M Gump; Andrew M Donson; Diane K Birks; Vladimir M Amani; Karun K Rao; Andrea M Griesinger; B K Kleinschmidt-DeMasters; James M Johnston; Richard C E Anderson; Amy Rosenfeld; Michael Handler; Lia Gore; Nicholas Foreman; Todd C Hankinson
Journal:  Acta Neuropathol Commun       Date:  2015-05-21       Impact factor: 7.801

Review 8.  Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.

Authors:  Juan Pedro Martinez-Barbera
Journal:  Neuropathol Appl Neurobiol       Date:  2015-04-23       Impact factor: 8.090

9.  Ghost cells: A journey in the dark….

Authors:  Monica Mehendiratta; Kundendu A Bishen; Karen Boaz; Yulia Mathias
Journal:  Dent Res J (Isfahan)       Date:  2012-12

10.  Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.

Authors:  John R Apps; Gabriela Carreno; Jose Mario Gonzalez-Meljem; Scott Haston; Romain Guiho; Julie E Cooper; Saba Manshaei; Nital Jani; Annett Hölsken; Benedetta Pettorini; Robert J Beynon; Deborah M Simpson; Helen C Fraser; Ying Hong; Shirleen Hallang; Thomas J Stone; Alex Virasami; Andrew M Donson; David Jones; Kristian Aquilina; Helen Spoudeas; Abhijit R Joshi; Richard Grundy; Lisa C D Storer; Márta Korbonits; David A Hilton; Kyoko Tossell; Selvam Thavaraj; Mark A Ungless; Jesus Gil; Rolf Buslei; Todd Hankinson; Darren Hargrave; Colin Goding; Cynthia L Andoniadou; Paul Brogan; Thomas S Jacques; Hywel J Williams; Juan Pedro Martinez-Barbera
Journal:  Acta Neuropathol       Date:  2018-03-14       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.